Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis

BACKGROUND: There is a need to synthesise the results of numerous randomised controlled trials evaluating the addition of therapies to androgen deprivation therapy (ADT) for men with metastatic hormone-sensitive prostate cancer (mHSPC). This systematic review aims to assess the effects of adding abi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rydzewska, Larysa H.M., Burdett, Sarah, Vale, Claire L., Clarke, Noel W., Fizazi, Karim, Kheoh, Thian, Mason, Malcolm D., Miladinovic, Branko, James, Nicholas D., Parmar, Mahesh K.B., Spears, Melissa R., Sweeney, Christopher J., Sydes, Matthew R., Tran, NamPhuong, Tierney, Jayne F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630199/
https://www.ncbi.nlm.nih.gov/pubmed/28800492
http://dx.doi.org/10.1016/j.ejca.2017.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630199/
https://www.ncbi.nlm.nih.gov/pubmed/28800492
http://dx.doi.org/10.1016/j.ejca.2017.07.003

Ejemplares similares